Market Overview:
The global IV fluid transfer drugs devices market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of chronic diseases, rising geriatric population, and technological advancements in infusion devices. Based on type, the global IV fluid transfer drugs devices market is segmented into infusion bags, infusion devices, and other types. The infusion bags segment is expected to account for the largest share of the market in 2018 owing to their wide use in hospitals and clinics across regions. Based on application, the hospital segment is expected to account for the largest share of the market in 2018 owing to increased demand for intravenous fluids for various treatments such as dehydration treatment and parenteral nutrition therapy.
Product Definition:
IV fluid transfer drugs devices are used to move fluids from one container to another. They are often used in hospitals and clinics to transfuse patients with blood or other fluids.
Infusion Bags:
Infusion bags are used to transfer IV fluid. They are majorly used in hospital settings for the infusion of drugs and fluids to patients. The growth factor that propels the market is increasing number of hospitals, rising prevalence of chronic diseases, and growing demand for home healthcare services.
The infusion bags market is segmented on the basis of product type which includes pre-filled syringes and vials/ Ampoules .
Infusion Devices:
Infusion devices and it's usage in IV fluid transfer drugs devices market is expected to grow at a lucrative rate during the forecast period. The infusion device sub-segment is further classified into catheters, central venous pressure monitoring catheter, peripheral intravenous catheter hub, peripherally inserted central venous catheter system (PICVC), percutaneous urinary drainage systems & indwelling urinary Catheters (PUDS) and other accessories.
Application Insights:
The market is segmented by application into hospitals, clinics and other sites. The hospitals segment dominated the overall industry in terms of revenue in 2017 owing to factors such as increasing healthcare spending and growing geriatric population across the globe. Moreover, an increase in hospital-acquired IV pumps has also positively influenced growth. For instance, according to a study published by NCBI, there was an increase of around 40% pump acquisition rate for patients hospitalized between 2010 - 2014 which further increased hospital acquired devices usage from 2014 - 2016.
Clinics are expected to be one of the fastest-growing segments over the forecast period due to factors such as rising awareness about better care management among clinicians regarding patient safety.
Regional Analysis:
North America dominated the global market in 2017. The presence of well-established healthcare infrastructure, high adoption rate of advanced technologies, and favorable reimbursement policies are some factors driving the growth of this regional market. Moreover, increasing number of conferences and events to raise awareness about IVF technology is also expected to boost demand for these devices during the forecast period.
Asia Pacific is anticipated to be one of fastest growing regions during the forecast period owing to rising geriatric population coupled with increasing prevalence diabetes in countries such as China and India. In addition, government initiatives encouraging R&D activities related to infusion therapy are also expected drive growth over the next eight years.
Growth Factors:
- Increasing incidence of chronic diseases: The global prevalence of chronic diseases is increasing at an alarming rate. This is primarily because of the changing lifestyles and dietary habits of people across the world. According to a study by the World Health Organization (WHO), non-communicable diseases are responsible for around 63% of all deaths worldwide. This number is expected to rise to 73% by 2030. This will create a large demand for IV fluid transfer drugs and devices, as they are essential for the treatment of chronic diseases.
- Technological advancements: The IV fluid transfer drugs and devices market is witnessing rapid technological advancements, with new products being launched regularly. These advancements are helping medical professionals treat patients more effectively and efficiently. They are also helping reduce the overall treatment costs, thus driving market growth further.
- Becton Dickinson & Company announced that it would be investing 0 million over five years in its R&D efforts aimed at developing next-generation medical technologies . Such investments will help drive innovation in this market and spur growth over the long term..
- it is estimated that
Scope Of The Report
Report Attributes
Report Details
Report Title
IV Fluid Transfer Drugs Devices Market Research Report
By Type
Infusion Bags, Infusion Devices, Other
By Application
Hospitals, Clinics, Other
By Companies
Bayer AG, Sanofi, Amedra Pharmaceuticals, ALK Abello, Novartis International AG, Unilife Corporation, Pfizer, Emerade, Ypsomed Holding AG, Biogen Idec, Inc, Emergent BioSolutions, Owen Mumford
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
250
Number of Tables & Figures
175
Customization Available
Yes, the report can be customized as per your need.
Global IV Fluid Transfer Drugs Devices Market Report Segments:
The global IV Fluid Transfer Drugs Devices market is segmented on the basis of:
Types
Infusion Bags, Infusion Devices, Other
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Clinics, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Bayer AG
- Sanofi
- Amedra Pharmaceuticals
- ALK Abello
- Novartis International AG
- Unilife Corporation
- Pfizer
- Emerade
- Ypsomed Holding AG
- Biogen Idec, Inc
- Emergent BioSolutions
- Owen Mumford
Highlights of The IV Fluid Transfer Drugs Devices Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Infusion Bags
- Infusion Devices
- Other
- By Application:
- Hospitals
- Clinics
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the IV Fluid Transfer Drugs Devices Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
IV fluid transfer devices are medical devices that allow fluids and other medications to be administered through a vein. These devices can be used in hospitals, clinics, or homes. IV fluid transfer devices come in different shapes and sizes, and they can be attached to the arm or leg.
Some of the major players in the iv fluid transfer drugs devices market are Bayer AG, Sanofi, Amedra Pharmaceuticals, ALK Abello, Novartis International AG, Unilife Corporation, Pfizer, Emerade, Ypsomed Holding AG, Biogen Idec, Inc, Emergent BioSolutions, Owen Mumford.
The iv fluid transfer drugs devices market is expected to register a CAGR of 5.8%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. IV Fluid Transfer Drugs Devices Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. IV Fluid Transfer Drugs Devices Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. IV Fluid Transfer Drugs Devices Market - Supply Chain
4.5. Global IV Fluid Transfer Drugs Devices Market Forecast
4.5.1. IV Fluid Transfer Drugs Devices Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. IV Fluid Transfer Drugs Devices Market Size (000 Units) and Y-o-Y Growth
4.5.3. IV Fluid Transfer Drugs Devices Market Absolute $ Opportunity
5. Global IV Fluid Transfer Drugs Devices Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. IV Fluid Transfer Drugs Devices Market Size and Volume Forecast by Type
5.3.1. Infusion Bags
5.3.2. Infusion Devices
5.3.3. Other
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global IV Fluid Transfer Drugs Devices Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. IV Fluid Transfer Drugs Devices Market Size and Volume Forecast by Application
6.3.1. Hospitals
6.3.2. Clinics
6.3.3. Other
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global IV Fluid Transfer Drugs Devices Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. IV Fluid Transfer Drugs Devices Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global IV Fluid Transfer Drugs Devices Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. IV Fluid Transfer Drugs Devices Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global IV Fluid Transfer Drugs Devices Demand Share Forecast, 2019-2026
9. North America IV Fluid Transfer Drugs Devices Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America IV Fluid Transfer Drugs Devices Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America IV Fluid Transfer Drugs Devices Market Size and Volume Forecast by Application
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Other
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America IV Fluid Transfer Drugs Devices Market Size and Volume Forecast by Type
9.7.1. Infusion Bags
9.7.2. Infusion Devices
9.7.3. Other
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America IV Fluid Transfer Drugs Devices Demand Share Forecast, 2019-2026
10. Latin America IV Fluid Transfer Drugs Devices Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America IV Fluid Transfer Drugs Devices Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America IV Fluid Transfer Drugs Devices Market Size and Volume Forecast by Application
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Other
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America IV Fluid Transfer Drugs Devices Market Size and Volume Forecast by Type
10.7.1. Infusion Bags
10.7.2. Infusion Devices
10.7.3. Other
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America IV Fluid Transfer Drugs Devices Demand Share Forecast, 2019-2026
11. Europe IV Fluid Transfer Drugs Devices Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe IV Fluid Transfer Drugs Devices Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe IV Fluid Transfer Drugs Devices Market Size and Volume Forecast by Application
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Other
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe IV Fluid Transfer Drugs Devices Market Size and Volume Forecast by Type
11.7.1. Infusion Bags
11.7.2. Infusion Devices
11.7.3. Other
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe IV Fluid Transfer Drugs Devices Demand Share, 2019-2026
12. Asia Pacific IV Fluid Transfer Drugs Devices Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific IV Fluid Transfer Drugs Devices Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific IV Fluid Transfer Drugs Devices Market Size and Volume Forecast by Application
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Other
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific IV Fluid Transfer Drugs Devices Market Size and Volume Forecast by Type
12.7.1. Infusion Bags
12.7.2. Infusion Devices
12.7.3. Other
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific IV Fluid Transfer Drugs Devices Demand Share, 2019-2026
13. Middle East & Africa IV Fluid Transfer Drugs Devices Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa IV Fluid Transfer Drugs Devices Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa IV Fluid Transfer Drugs Devices Market Size and Volume Forecast by Application
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Other
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa IV Fluid Transfer Drugs Devices Market Size and Volume Forecast by Type
13.7.1. Infusion Bags
13.7.2. Infusion Devices
13.7.3. Other
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa IV Fluid Transfer Drugs Devices Demand Share, 2019-2026
14. Competition Landscape
14.1. Global IV Fluid Transfer Drugs Devices Market: Market Share Analysis
14.2. IV Fluid Transfer Drugs Devices Distributors and Customers
14.3. IV Fluid Transfer Drugs Devices Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. Bayer AG
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Sanofi
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Amedra Pharmaceuticals
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. ALK Abello
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Novartis International AG
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Unilife Corporation
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Pfizer
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Emerade
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Ypsomed Holding AG
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Biogen Idec, Inc
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. Emergent BioSolutions
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. Owen Mumford
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
